Stable expression of a foreign protein by a replication-competent rubella viral vector (Q37640717)

21 August 2017

title

Stable expression of a foreign protein by a replication-competent rubella viral vector (English)

1 reference

21 August 2017

1 reference

Angelo Spadaccini

1 reference

21 August 2017

Konstantin Virnik

1 reference

21 August 2017

Yisheng Ni

1 reference

21 August 2017

Kirk Prutzman

1 reference

21 August 2017

Ira Berkower

1 reference

21 August 2017

language of work or name

English

0 references

publication date

27 November 2009

1 reference

21 August 2017

1 reference

inferred from page(s)

published in

Vaccine

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

1181-1187

1 reference

Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Molecular biology of rubella virus.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

inferred from DOI database lookup

7 January 2021

based on heuristic

Development of a rubella virus vaccine expression vector: use of a picornavirus internal ribosome entry site increases stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Complementation of a deletion in the rubella virus p150 nonstructural protein by the viral capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Replication complexes associated with the morphogenesis of rubella virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Rubella virus RNA replication is cis-preferential and synthesis of negative- and positive-strand RNAs is regulated by the processing of nonstructural protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Development of Sindbis Viruses Encoding nsP2/GFP Chimeric Proteins and Their Application for Studying nsP2 Functioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Formation of nsP3-Specific Protein Complexes during Sindbis Virus Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Alphavirus-based expression vectors: strategies and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genesin Vitroand Immunization against Heterologous Pathogensin Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Replicating and non-replicating viral vectors for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.037

10.1016/J.VACCINE.2009.11.037

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference